JP Morgan Chase’s Zymergen Inc. Common Stock ZY Stock Holding History

JP Morgan Chase’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-616,473	Closed	-$1.71M	–	7363
2022 Q3	$1.71M	Sell	616,473 -1,705,955	-73%	-$4.14M	﹤0.01%	3600
2022 Q2	$2.86M	Sell	2,322,428 -1,847,595	-44%	-$3.1M	﹤0.01%	3263
2022 Q1	$12.1M	Buy	4,170,023 +606,588	+17%	+$2.58M	﹤0.01%	2186
2021 Q4	$23.8M	Buy	3,563,435 +51,260	+1%	+$498K	﹤0.01%	1677
2021 Q3	$46.3M	Buy	3,512,175 +1,898,974	+118%	+$40.3M	0.01%	1220
2021 Q2	$64.5M	Buy	+1,613,201	New	+$63.7M	0.01%	1098

JP Morgan Chase's ZY Position: Q4 2022 in Review

JP Morgan Chase sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 616,473 shares — an estimated $1.71M sold.

JP Morgan Chase first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $64.5M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

JP Morgan Chase reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
JP Morgan Chase sold 616,473 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $1.71M.
JP Morgan Chase first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
JP Morgan Chase's Zymergen Inc. Common Stock position peaked at $64.5M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.